Topas Therapeutics
Business Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Falkenried 88, Hamburg, Hamburg, 20251, ...Phone Number
+49 40302089010Website
www.topas-therapeutics.comRevenue
$6 MillionIndustry
ZI Rank: 1
About Topas Therapeutics
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Topas Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Topas Therapeutics recently announced quarterly report
Product Launch: Get notified when Topas Therapeutics launches new products
Check out if Topas Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Topas Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Topas Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Topas Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Topas Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Topas Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Topas Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Topas Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Topas Therapeutics.
Topas Therapeutics financials insights
Gather financial insights about Topas Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$16.5M
Series B
$26M
Topas Therapeutics Tech Stack
A closer look at the technologies used by Topas Therapeutics
Most Recent Scoops
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Topas Therapeutics
Topas Therapeutics is pioneering a novel approach to establish immune tolerance in autoimmune and immune-mediated diseases through its proprietary antigen-specific nanoparticle technology. The company's lead candidate, TPM502, has shown promising results in a Phase 2a clinical trial for celiac disease and is preparing for a global Phase 2b trial. T... Read More
